Development by Design Best Practices in Pharmaceutical Development José Luís Santos, PhD

Similar documents
Best Practices in Pharmaceutical Technology Filipe Gaspar

Quality by Design Approaches to Analytical Methods -- FDA Perspective. Yubing Tang, Ph.D. FDA/CDER/ONDQA AAPS, Washington DC October 25, 2011

QbD in der Praxis systematisches Vorgehen bei der Entwicklung pharmazeutischer Herstellprozesse. Adrian Funke

Workshop B Control Strategy

Multivariate Chemometric and Statistic Software Role in Process Analytical Technology

PHARMACEUTICAL DEVELOPMENT

Process Validation: Practical Aspects of the New FDA Guidance

What to control? CQAs and CPPs

Workshop A Design Space (DS)

QbD Considerations for Analytical Methods - FDA Perspective

Control Strategy Case Studies

Best Practice In A Change Management System

An Industry White Paper

C 5. chemical development contract research custom synthesis cgmp API manufacturing commercial production. Welcome to

Enrolling Yourself on a Course (Self Enrolment)

Mixing in the process industry: Chemicals Food Pharmaceuticals Paper Polymers Minerals Environmental. Chemical Industry:

Quality by Design (QbD) Overview

Pharmaceutical Quality Systems: US Perspective

Pharmaceutical Engineering: The Lisbon Masters Program

Multivariate Tools for Modern Pharmaceutical Control FDA Perspective

Q8(R2): Pharmaceutical Development

Dedicated Project Management

Making Improvement Work in Pharmaceutical Manufacturing Some Case Studies. Ronald D. Snee

Top and Bottom Spray Fluid Bed Granulation Process

Process analytical technology PAT for the life sciences industry

A Hybrid Catalytic Route to Fuels from Biomass Syngas Alice Havill Senior Process Engineer Project Principle Investigator

An FDA Perspective on Post- Approval Change Management for PAT and RTRT

PRODUCT DEVELOPMENT GUIDE

ICH guideline Q11 on development and manufacture of drug substances (chemical entities and biotechnological/ biological entities)

Big Data to Design Quality

Assay Development and Method Validation Essentials

QbD Approach to Assay Development and Method Validation

A novel method for the synthesis of peptides

A Preliminary Proposal for a Pharmaceutical Engineering Graduate Program

STOPPERS PREFILLABLE SYRINGE PLUNGERS. The New Definition of High-Quality Components

Greater Nanticoke Area School District Chemistry Standards. Standard 3.1. Unifying Themes

NEW CHEMICAL ENTITIES

Specific Challenges in Large-Scale Manufacturing of Peptide as API s Presentation at TIDES Conference, Las Vegas, April 25 29, 2004

QUALITY BY DESIGN (QBD) : A COMPLETE REVIEW

PHARMACEUTICAL REFERENCE STANDARDS

Implementing Lifecycle Validation Practices at Contract Manufacturing Organizations

Quality Risk Management Tools Quality Risk Management Tool Selection When to Select FMEA: QRM Tool Selection Matrix

Risk-Based Change Management Using QbD Principles

Risk analysis and management is the cornerstone

FILTRATION SOLUTIONS PhARmAceUTIcAL manufacturing FILTRATION SPecIALISTS

Computational Fluid Dynamic Modeling Applications

LifeTein in Industrial Production of Therapeutic Peptides. Phil Moore, PhD Director of Business Development LifeTein LLC, NJ, USA

B i o s o l u t i o n s

Risk Assessment Tools for Identifying Hazards and Evaluating Risks Associated with IVD Assays

Risk assessment is used as a

Process Analytical Technology (PAT) Capabilities and Implementations under QbD Principles QbD and PAT Department

PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7: NON-STERILE PROCESS VALIDATION

ENGINEERING COUNCIL OF SOUTH AFRICA. Discipline-Specific Training Guideline for Candidate Engineers in Chemical Engineering

Peptide purification strategies

Data Analysis and Effectiveness Models

Master's Programs. Applied Chemisty. Subject

Best Practices in Statistical Process Monitoring of Biopharmaceutical Manufacturing Operations

Michael Kickuth and Thomas Friedli

Pharmaceutical Quality Management System: Current Concept

Highly Potent APIs The right platform, people and procedures for successful development and manufacturing

Guidance for Industry

IMPURITIES IN NEW DRUG PRODUCTS

Prentice Hall. Chemistry (Wilbraham) 2008, National Student Edition - South Carolina Teacher s Edition. High School. High School

Implementing New USP Chapters for Analytical Method Validation

Risk Assessment for Medical Devices. Linda Braddon, Ph.D. Bring your medical device to market faster 1

STEADY STATE MODELING AND SIMULATION OF HYDROCRACKING REACTOR

A Course in Particle and Crystallization Technology

SKI Coal Gasification Technology. Feb. 23, 2012

experiment5 Understanding and applying the concept of limiting reagents. Learning how to perform a vacuum filtration.

Pre-requisites

Risk-Based Environmental Monitoring. Marsha Stabler Hardiman Senior Consultant Concordia ValSource Wednesday September 17, 2014 FDA/PQRI

Post-Approval Change Management: Challenges and Opportunities An FDA Perspective

In Situ Spectroscopy. Reaction Analysis and PAT Tools From Research to Manufacturing

Quality Risk Management Understanding and Control the Risk in Pharmaceutical Manufacturing Industry

GEA Niro Pharmaceutical GMP Spray Drying facility. Spray drying process development and contract manufacturing. engineering for a better world

Hamari Chemicals, Ltd.

SAS Fraud Framework for Banking

Guidance for Industry

Guideline on Process Validation

QUALITY RISK MANAGEMENT (QRM): A REVIEW

White Paper. By Jack Vinson, PhD, Product Manager, Batch Process Development, Aspen Technology

Software Quality. Unit 2. Advanced techniques

Operations Management and the Integrated Manufacturing Facility

Course Overview Lean Six Sigma Green Belt

VALIDATION, MODELING, AND SCALE-UP OF CHEMICAL LOOPING COMBUSTION WITH OXYGEN UNCOUPLING

XPure. Simulated Moving Bed. System for Chromatography and Ion exchange applications. Better solutions for your purification needs

What is Process Validation?

Workflow System for Paperless Air Monitoring Powered by MODA. Presented by

S.L. Chang, S.A. Lottes, C.Q. Zhou,** B. Golchert, and M. Petrick

ICH Q10 and Change Management: Enabling Quality Improvement

Library Guide: Pharmaceutical GMPs

Workshop on process validation

Custom Synthesis. Reliable, Flexible and Competitive THE KEY SOLUTION PROVIDER A FINE CHEMICAL COMPANY. About ISOCHEM

FT-NIR for Online Analysis in Polyol Production

Quality Risk Management ICH Q9 & ISO Presented by Michael Kerr 11 th November 2011

SIMCA 14 MASTER YOUR DATA SIMCA THE STANDARD IN MULTIVARIATE DATA ANALYSIS

DEPARTMENT OF PROCESS OPERATIONS TECHNOLOGY Part-Time - Bachelor Degree Plan

ICH guideline Q8, Q9 and Q10 - questions and answers volume 4

Thème Analytical Chemistry ECUE composant l UE

Benefits Achieved Using Online Analytics in a Batch Manufacturing Facility

Transcription:

Development by Design Best Practices in Pharmaceutical Development José Luís Santos, PhD November 2014

Agenda Advanced Tools in Development and Manufacturing Excellent Development and Manufacturing Quality by Design at Hovione

Advanced Tools in Development and Manufacturing DEVELOPMENT Risk Assessment Design of Experiments Modeling Tools Scale-Up Methods Scale-Down / Miniaturization Process Analytical Technology MANUFACTURING Lean 6 Sigma Visual Stream Mapping Failure Mode and Effect Analysis Multivariate Analysis 8D Poka-Yoke OEE

Modeling Tools Adjust model complexity Concept Development Solution Domain (Problem statement) 1st principles models Fundamentals captured (months) Mechanistic models Main mechanisms captured (weeks) Statistical models Behaviour captured (days) Best modeling approach: considering the problem statement, keep things as simple as possible, but not simpler

Modeling Tools Case-study: chemical synthesis Problem statement (troubleshooting) catalyst catalyst During an alkylation reaction, the content of raw material increased after IPC (upon scale-up). V = 0.1 L Hypothesis: poor mixing leading to un-reacted raw material accumulation; detailed analysis needed. Approach Axial & radial mixing patterns should be compared in detail for the lab and commercial-scale reactors. 1 st principles V = 2000 L For the 2000 L reactor, ~ zero velocity (stagnant fluid) is observed in the region below the impeller. Impeller was re-designed; problem was solved.

Scale-up Case-study: spray drying Droplet size correlations Thermodynamic space Heat and mass balance CFD Scale-up methodology

Scale-down Case-study: spray drying Commercial unit Lab unit D v 50 = 82 mm span = 1.7 bulk density = 0.29 kg/l tap density = 0.40 kg/l solvent = 5% w/w D v 50 = 83 mm span = 1.5 bulk density = 0.34 kg/l tap density = 0.42 kg/l solvent = 7% w/w

-0.3-0.2-0.1 0 0.1 0.2 0.3 0.2 0.1-0.1-0.2-0.3-0.4 0 Process Analytical Technology Chemical Processes Handheld NIR Raw materials identification and qualification UV photometry Refractometry Concentration and end-point determination FBRM Crystals growth dynamics Raw material dispensing Reaction Purification Crystallization Drying Raman spectroscopy Reaction conversion and polymorphs formation FT-IR spectroscopy Reaction conversion and polymorphs formation Prediction XR02036 % (w/w) 20 18 16 14 12 10 8 6 4 2 0 y = 0.9393x + 0.4461 R 2 = 0.9334 R = 0.97 O-H O-H 0 2 4 6 8 10 12 14 16 18 20 C-OH C-OH C-OH Raman and FT-IR spectroscopy Concentration and polymorph conversion NIR spectroscopy Drying end-point and solid state characterization XR02036 % (w/w)

Process output Process output (actual) Multivariate Analysis Raw materials Synthesis Downstream Final product Quality attributes (e.g.: purity) or process performance indicators (e.g.: yield) Process inputs Impact of process inputs on a process output Higher the absolute value => greater impact Process output (predicted)

Statistical Process Control Control Chart

How to use FMEA? FMEA PROCESS Team Definition Present Context Purpose to the team Failure identification risk evaluation Corrective / Preventive actions definition New risk evaluation Document risk analysis 1 2 3 4 5 6 Actions implementation Follow up final evaluation - List ALL possible failures - Classification and quantification (1 to 10) of failures based on: Frequency (F)/ probability of failure occurs Severity (S) of the effect Detection (D) of the failure (capacity to detect) - Prioritization by calculating Risk Priority Number: RPN = F x S x D

Agenda Advanced Tools in Development and Manufacturing Excellent Development and Manufacturing Quality by Design at Hovione

Excellent Development and Manufacturing New approach at Hovione Established methodologies: Britest, QbD, Lean State-of-the-art tools Throughout project life-cycle Site independent Accessible by everyone Aligned with regulators (FDA & EMA)

Industrialization (QbD) Manufacturing (LEAN) Technical screening (BRITEST) Excellent Development and Manufacturing Guidelines New project Technical / Business Evaluation FAMILIARIZATION Stage #1 Technical Screening BRITEST driven Receive a Chemical Structure Route Scouting (change conditions) Receive Chemical Process (route defined) Familiarization Receive an API and target specification Lab scale formulation development N for Chem Does it work? PRELIMINARY RISK ASSESSMENT N for SD Technical / Business Evaluation Definition of pcma s pcqa s pcpp s Preliminary PIH & PHA LAB SCALE DEVELOPMENT and PILOT SCALE Stage #2 Industrialization QbD driven No No INDUSTRIALIZATION Lab Scale Development HAZOP and What If, Ok? Final Process OK for Pilot Scale? Pilot Scale Campaign Technical Evaluation Yes Any Campaign Issues? Technical Evaluation PROCESS DESIGN SPACE Design & Full PHA, Operating HSEE Space Aspects Business Evaluation VALIDATION and MANUFACTURING Stage #3 Manufacturing LEAN driven Demo or engineering batch Validation Batches 1 st Commercial Batch MANUFACTURING Continuous Improvement (3P, LEAN, PQLI) QbD Filling Report / Technical / Business Evaluation

Agenda Advanced Tools in Development and Manufacturing Excellent Development and Manufacturing Quality by Design at Hovione

QbD at Hovione 1st project under QbD 2nd project 3rd project 4th project 5th project Sucesfull PAI on QbD submission Approved Approved 6th 7th 8th projects 2007 2008 2009 2010 2011 2012-14 Britest tools used in CRD Lean implementation QbD implementation EDaM implementation (Britest + QbD + Lean) Relevant Milestones Hovione s PAT and QbD speakers in International Conferences

QbD at Hovione Science and Risk based Target profile (quality, safety, efficacy) Regulatory filing & approval CQA definition (critical quality attributes) Risk assessment I (rank process parameters) Process Development (statistical, mechanistic) PAT Strategy Change control & implementation PAT Implementation Design space & NOR (feasible & preferable) Process control strategy Criticality analysis Risk assessment II (process FMEA)

QbD at Hovione Development by Design 1 st QbD filing 2 nd QbD filing Today # Runs at full scale ~ 270 ~ 60 ~ 9 Material needed ~ 900 kg (~ $9 MM*) ~ 200 kg (~ $2 MM*) ~ 40 kg (~ $0.4 MM*) Time required at full scale ~ 4 months ~ 4 weeks ~ 4 days * Assumed $10,000/kg of API as reference

10 Years of Commercial Spray Drying The most extensive commercial spray drying facilities in the world

Thank you for your attention. José Luís Santos, Particle Engineering Services jlsantos@hovione.com hovione.com